Right, mozz. This is now a significant turnaround from 0.50 and...

Right, mozz. This is now a significant turnaround from 0.50 and there are signs that sellers are now more patient than buyers.

As to what's next, I don't know. Maybe a trial update (not sure when that's due), maybe a top-5 pharma update, maybe a collaboration with another pharma, or maybe the sale of the orthopedics/tissue engineering IP. That last one could be significant if they get a good price, but I don't have a clue what a good price would be.

Pezz